IndiaApproval for emergency use of 'Kovax', praised by government committee

Approval for emergency use of ‘Kovax’, praised by government committee

New Delhi
An expert committee of the country’s Central Drugs Authority has praised the Serum Institute of India’s permission for emergency use of the COVID-19 vaccine ‘Covovax’ subject to certain conditions. Official sources gave this information on Monday.

Prakash Kumar Singh, director of government and regulatory affairs at the Serum Institute of India (SII), submitted an application to the Drug Controller of India (DCGI) in October, requesting it to grant marketing permission for limited use of Kovovax in emergency situations. Was.

An expert committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) reviewed the Emergency Use Permission (EUA) application for the second time on Monday and after detailed deliberations, an official source said. Recommended to approve emergency use.